Strategies in complex disease mapping

Current Opinion in Genetics and Development

Volumn 10, Issue 3, 2000, Pages 330-334

  Johnson, Gillian CL ^a   Todd, John A ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ASTHMA; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; DISEASE PREDISPOSITION; GENE LINKAGE DISEQUILIBRIUM; GENE MAPPING; GENE SEQUENCE; GENETIC POLYMORPHISM; HUMAN; MOLECULAR GENETICS; PRIORITY JOURNAL; REVIEW;

CHROMOSOME MAPPING; GENETIC DISEASES, INBORN; GENETICS, MEDICAL; GENOME, HUMAN; HUMANS; POLYMORPHISM, GENETIC;

EID: 0034068308     PISSN: 0959437X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-437X(00)00075-7     Document Type: Review

References (65)

1. Risch N., Merikangas K. The future of genetic studies of complex human diseases. Science. 273:1996;1516-1517.
2. Chakravarti A. Population genetics - making sense out of sequence. Nat Genet. 21:1999;56-60.
3. Collins F.S., Guyer M.S., Charkravarti A. Variations on a theme: cataloguing human DNA sequence variation. Science. 278:1997;1580-1581.
4. Todd J.A. Multifactorial diseases: ancient gene polymorphism at quantitative trait loci and a legacy of survival during our evolution. Scriver C.R., Beaudet A.L., Sly W.S., Valle D.L., Vogelstein B., Childs B. The Metabolic and Molecular Basis of Inherited Disease. 2000;McGraw-Hill, New York.
5. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W., Roses A.D., Haines J.L., Pericak-Vance M.A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 261:1993;921-923.
6. Bennett S.T., Lucassen A.M., Gough S.C.L., Powell E.E., Undlien D.E., Pritchard L.E., Merriman M.E., Kawaguchi Y., Dronsfield M., Pociot F.et al. Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus. Nat Genet. 9:1995;284-292.
7. Cucca F., Todd J.A. HLA susceptibility to type 1 diabetes: methods and mechanisms. Browning M.J., McMichael A.J. HLA and MHC: Genes, Molecules and Function. 1996;383-406 BIOS Scientific Publishers, Oxford.
8. Terwilliger J.D., Weiss K.M. Linkage disequilibrium mapping of complex disease: fantasy or reality? Curr Opin Biotechnol. 9:1998;578-594.
9. Wright A.F., Carothers A.D., Pirastu M. Population choice in mapping genes for complex diseases. Nat Genet. 23:1999;397-404. An informative review describing the two main models of complex disease and potential of populations with different demographies when mapping complex disease genes.
10. Van Hauwe P., Coucke P.J., Declau F., Kunst H., Ensink R.J., Marres H.A., Cremers C.W.R.J., Djelantik B., Smith S.D., Kelley P.et al. Deafness linked to DFNA2: one locus but how many genes? Nat Genet. 21:1999;263. This short correspondence highlights the complex locus heterogeneity seen in a Mendelian autosomal dominant disorder, in which at least two independent disease genes map to one linked chromosomal region. Multiple susceptibility genes may well account for the linkage seen in chromosomal regions implicated in complex disease.
11. Cox N.J., Frigge M., Nicolae D.L., Concannon P., Hanis C.L., Bell G.I., Kong A. Loci on chromosomes 2 (NIDDM1) and 15 interact to increase susceptibility to diabetes in Mexican Americans. Nat Genet. 21:1999;213-215. Using a method that exploits potential interactions between susceptibility loci, this group demonstrates additional evidence for two putative susceptibility genes involved in type 2 diabetes.
12. Mein C.A., Esposito L., Dunn M.G., Johnson G.C.L., Timms A.E., Goy J.V., Smith A.N., Sebag-Montefiore L., Merriman M.E., Wilson A.J., Todd J.A. A search for type 1 diabetes susceptibility genes in families from the United Kingdom. Nat Genet. 19:1998;297-300.
13. Xiong M., Jin L. Comparison of the power and accuracy of biallelic and microsatellite markers in population-based gene-mapping methods. Am J Hum Genet. 64:1999;629-640.
14. Collins F.S., Patrinos A., Jordan E., Chakravarti A., Gesteland R., Walters L. New goals for the U.S. Human Genome Project: 1998-2003. Science. 282:1998;682-689.
15. Wang D.G., Fan J.B., Siao C.J., Berno A., Young P., Sapolsky R., Ghandour G., Perkins N., Winchester E., Spencer J.et al. Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome. Science. 280:1998;1077-1082.
16. Taillon-Miller P.P.E., Kwok P.Y. Efficient approach to unique single-nucleotide polymorphism discovery. Genome Res. 9:1999;499-505.
17. Marth G.T., Korf I., Yandell M.D., Yeh R.T., Gu Z., Zakeri H., Stitziel N.O., Hillier L., Kwok P.Y., Gish W.R. A general approach to single-nucleotide polymorphism discovery. Nat Genet. 23:1999;452-456.
18. Buetow K.H., Edmonson M.N., Cassidy A.B. Reliable identification of large numbers of candidate SNPs from public EST data. Nat Genet. 21:1999;323-325. This group uses existing sequence data as a resource for identifying SNPs, a potentially cheaper method of identifying polymorphisms within coding regions of genes.
19. Landegren U., Nilsson M., Kwok P.Y. Reading bits of genetic information: methods for single-nucleotide polymorphism analysis. Genome Res. 8:1998;769-776. This manuscript gives an overview explaining why SNPs are so popular and describes new technologies under development that will hopefully allow these markers to be typed on a huge scale.
20. Hacia J.G., Collins F.S. Mutational analysis using oligonucleotide microarrays. J Med Genet. 36:1999;730-736.
21. Lyamichev V., Mast A.L., Hall J.G., Prudent J.R., Kaiser M.W., Takova T., Kwiatkowski R.W., Sander T.J., de Arruda M., Arco D.A.et al. Polymorphism identification and quantitative detection of genomic DNA by invasive cleavage of oligonucleotide probes. Nat Biotechnol. 17:1999;292-296.
22. Mein C.A., Barratt B.J., Dunn M.G., Seigmund T., Smith A.N., Esposito L., Nutland S., Stevens H.E., Wilson A.J., Jarvis N.et al. Evaluation of single nucleotide polymorphism (SNP) typing with Invader on PCR amplicons and it's automation. Genome Research. 10:2000;330-343.
23. Pastinen T., Kurg A., Metspalu A., Peltonen L., Syvanen A.C. Minisequencing: a specific tool for DNA analysis and diagnostics on oligonucleotide arrays. Genome Res. 7:1997;606-614.
24. Kruglyak L. Prospects for whole-genome linkage disequilibrium mapping of common disease genes. Nat Genet. 22:1999;139-144. In this paper, Krugylak estimates the amount of 'useful' LD that is likely to occur between common alleles in the general population. If his conclusions are correct it paints a bleak picture, at least in the foreseeable future, for genome-wide association mapping.
25. Brown P.O., Botstein D. Exploring the new world of the genome with DNA microarrays. Nat Genet. 21:1999;33-37.
26. Duggan D.J., Bittner M., Chen Y., Meltzer P., Trent J.M. Expression profiling using cDNA microarrays. Nat Genet. 21:1999;10-14.
27. Clement K., Vaisse C., Lahlou N., Cabrol C., Pelloux V., Cassuto D., Gourmelen M., Dina C., Chambaz J., Lacorte J.M.et al. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature. 392:1998;398-401.
28. Yaswen L., Diehl N., Brennen M.B., Hochgeschwender U. Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin. Nat Med. 5:1999;1066-1070.
29. Cambien F., Poirier O., Nicaud V., Herrmann S.M., Mallet C., Ricard S., Behague I., Hallet V., Blanc H., Loukaci V.et al. Sequence diversity in 36 candidate genes for cardiovascular disorders. Am J Hum Genet. 65:1999;183-191. This excellent paper looks at sequence diversity and LD between variants in 36 genes. In the light of their results, the authors advocate both genome-wide association studies coupled with more detailed characterisations of specific candidate genes as complementary approaches.
30. Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N., Lane C.R., Lim E.P., Kalayanaraman N., Nemesh J.et al. Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nat Genet. 22:1999;231-238. This paper describes the sequence diversity of 106 human genes. The authors report differences in the rate of polymorphism for noncoding, degenerate and nondegenerate sites and comment on the implications for disease association studies.
31. Halushka M.K., Fan J.B., Bentley K., Hsie L., Shen N., Weder A., Cooper R., Lipshutz R., Chakravarti A. Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis. Nat Genet. 22:1999;239-247. The authors report the pattern and frequency of SNPs in 75 candidate human genes for blood-pressure homeostasis and hypertension. They show the strong role of natural selection in shaping human gene variation.
32. Nickerson D.A., Taylor S.L., Weiss K.M., Clark A.G., Hutchinson R.G., Stengard J., Salomaa V., Vartiainen E., Boerwinkle E., Sing C.F. DNA sequence diversity in a 9.7-kb region of the human lipoprotein lipase gene. Nat Genet. 19:1998;233-240.
33. Rieder M.J., Taylor S.L., Clark A.G., Nickerson D.A. Sequence variation in the human angiotensin converting enzyme. Nat Genet. 22:1999;59-62.
34. Long A.D., Lyman R.F., Langley C.H., Mackay T.F. Two sites in the Delta gene region contribute to naturally occurring variation in bristle number in Drosophila melanogaster. Genetics. 149:1998;999-1017.
35. Clark A.G., Weiss K.M., Nickerson D.A., Taylor S.L., Buchanan A., Stengard J., Salomaa V., Vartiainen E., Perola M., Boerwinkle E., Sing C.F. Haplotype structure and population genetic inferences from nucleotide-sequence variation in human lipoprotein lipase. Am J Hum Genet. 63:1998;595-612.
36. Abel L., Muller-Myhsok B. Maximum-likelihood expression of the transmission/disequilibrium test and power considerations. Am J Hum Genet. 63:1998;664-667.
37. Tu I.P., Whittemore A.S. Power of association and linkage tests when the disease alleles are unobserved. Am J Hum Genet. 64:1999;641-649. This manuscript highlights the potential problems when relying on linkage disequilibrium between the disease variant and the genetic marker to detect any disease association.
38. Morton N.E., Collins A. Tests and estimates of allelic association in complex inheritance. Proc Natl Acad Sci USA. 95:1998;11389-11393.
39. Huang J., Jiang Y. Linkage detection adaptive to linkage disequilibrium: the disequilibrium maximum-likelihood-binomial test for affected-sibship data. Am J Hum Genet. 65:1999;1741-1759.
40. Zhao L.P., Aragaki C., Hsu L., Quiaoit F. Mapping of complex traits by single-nucleotide polymorphisms. Am J Hum Genet. 63:1998;225-240.
41. Editorial: Freely associating. Nat Genet 1999, 22:1-2.
42. de la Chapelle A., Wright F.A. Linkage disequilibrium mapping in isolated populations: the example of Finland revisited. Proc Natl Acad Sci USA. 95:1998;12416-12423.
43. Kruglyak L. Genetic isolates: separate but equal? Proc Natl Acad Sci USA. 96:1999;1170-1172.
44. •] that founder populations such as the Finns may not provide a significant advantage for linkage disequilibrium mapping of common disease genes.
45. Laan M., Paabo S. Demographic history and linkage disequilibrium in human populations. Nat Genet. 17:1997;435-438.
46. Chakraborty R., Weiss K.M. Admixture as a tool for finding linked genes and detecting that difference from allelic association between loci. Proc Natl Acad Sci USA. 85:1988;9119-9123.
47. McKeigue P.M. Mapping genes that underlie ethnic differences in disease risk: methods for detecting linkage in admixed populations, by conditioning on parental admixture. Am J Hum Genet. 63:1998;241-251.
48. Lander E., Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet. 11:1995;241-247.
49. Kruglyak L. What is significant in whole-genome linkage disequilibrium studies? Am J Hum Genet. 61:1997;810-812.
50. Elston R.C. Methods of linkage analysis - and the assumptions underlying them. Am J Hum Genet. 63:1998;931-934.
51. Zhao H., Merikangas K.R., Kidd K.K. On a randomization procedure in linkage analysis. Am J Hum Genet. 65:1999;1449-1456.
52. Concannon P., Ewens-Gogolin K.J., Hinds D., Wapelhorst B., Morrison V.A., Stirling B., Mitra M., Farmer J., Williams S.R., Cox D.R. A second-generation screen of the human genome for susceptibility to insulin-dependent diabetes mellitus. Nat Genet. 19:1998;292-296.
53. Lernmark A., Ott J. Sometimes it's hot, sometimes it's not. Nat Genet. 19:1998;213-214.
54. Long A.D., Langley C.H. The power of association studies to detect the contribution of candidate genetic loci to variation in complex traits. Genome Res. 9:1999;720-721. This paper examines the power of different association-based analyses to implicate SNPs contributing to disease susceptibility in candidate gene regions. Although based on simplistic population models, the authors make intelligent comments about experimental design concerning sample size, use of statistics, and SNP density.
55. Roberts S.B., MacLean C.J., Neale M.C., Eaves L.J., Kendler K.S. Replication of linkage studies of complex traits: an examination of variation in location estimates. Am J Hum Genet. 65:1999;876-884.
56. Vyse T.J., Todd J.A. Genetic analysis of autoimmune disease. Cell. 85:1996;311-318.
57. Becker K.G., Simon R.M., Bailey-Wilson J.E., Freidlin B., Biddison W.E., McFarland H.F., Trent J.M. Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases. Proc Natl Acad Sci USA. 95:1998;9979-9984.
58. Becker K.G. Comparative genetics of type 1 diabetes and autoimmune disease: common loci, common pathways? Diabetes. 48:1999;1353-1358.
59. •,55].
60. Lyons P.A., Wicker L.S. Localising quantitative trait loci in the NOD mouse model of Type 1 diabetes. Theofilopoulos A.N. Genes and Genetics of Autoimmunity. 1999;208-225 Karger, Basel. An informative review detailing the problems encountered when mapping a complex disease gene in the NOD mouse.
61. Todd J.A., Mijovic C., Fletcher J., Jenkins D., Bradwell A.R., Barnett A.H. Identification of susceptibility loci for insulin-dependent diabetes mellitus by trans-racial gene mapping. Nature. 338:1989;587-589.
62. Degli-Esposti M.A., Abraham L.J., McCann V., Spies T., Christiansen F.T., Dawkins R.L. Ancestral haplotypes reveal the role of the central MHC in the immunogenetics of IDDM. Immunogenetics. 36:1992;345-356.
63. Schunkert H. Polymorphism of the angiotensin-converting enzyme gene and cardiovascular disease. J Mol Med. 75:1997;867-875.
64. Keavney B., McKenzie C.A., Connell J.M., Julier C., Ratcliffe P.J., Sobel E., Lathrop M., Farrall M. Measured haplotype analysis of the angiotensin-I converting enzyme gene. Hum Mol Genet. 7:1998;1745-1751.
65. Farrall M., Keavney B., McKenzie C., Delepine M., Matsuda F., Lathrop G.M. Fine-mapping of an ancestral recombination breakpoint in DCP1. Nat Genet. 23:1999;270-271. Using data generated from [33], this paper demonstrates that ancestral haplotype breakpoint mapping (see [4,61]), can eliminate the most 5′ end of the DCP1 gene from harbouring the variant causing variation in enzyme levels.